Literature DB >> 11353583

Sexual dysfunction and depression.

S N Seidman1, S P Roose.   

Abstract

Sexual functioning is generally impaired during depression. Interest in the relationship between sexual dysfunction and depression has risen substantially, prompted primarily by 1) the 1998 Food and Drug Administration approval of sildenafil citrate as the first oral therapy of erectile dysfunction, and 2) the widespread clinical use of selective serotonin reuptake inhibitors, which prominently impair orgasm, and possibly libido and arousal. In this paper, we first review the phenomenology of sexual dysfunction and important contributing factors, such as age and illness, and then focus on the clinical assessment and therapeutic interventions used for sexual dysfunction in depressed individuals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353583     DOI: 10.1007/s11920-001-0053-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  45 in total

Review 1.  Empirically validated treatment for sexual dysfunction.

Authors:  J R Heiman; C M Meston
Journal:  Annu Rev Sex Res       Date:  1997

2.  Intermittent amantadine for fluoxetine-induced anorgasmia.

Authors:  R Balon
Journal:  J Sex Marital Ther       Date:  1996

Review 3.  Andropause: a misnomer for a true clinical entity.

Authors:  A Morales; J P Heaton; C C Carson
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

4.  Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction.

Authors:  R C Schiavi; D White; J Mandeli; A C Levine
Journal:  Arch Sex Behav       Date:  1997-06

Review 5.  Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature.

Authors:  I P Spector; M P Carey
Journal:  Arch Sex Behav       Date:  1990-08

6.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

7.  The role of androgen in the maintenance of sexual functioning in oophorectomized women.

Authors:  B B Sherwin; M M Gelfand
Journal:  Psychosom Med       Date:  1987 Jul-Aug       Impact factor: 4.312

8.  Increased incidence of depressive symptoms in men with erectile dysfunction.

Authors:  R Shabsigh; L T Klein; S Seidman; S A Kaplan; B J Lehrhoff; J S Ritter
Journal:  Urology       Date:  1998-11       Impact factor: 2.649

9.  Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression.

Authors:  R C Casper; D E Redmond; M M Katz; C B Schaffer; J M Davis; S H Koslow
Journal:  Arch Gen Psychiatry       Date:  1985-11

Review 10.  Psychophysiological models of female sexual response.

Authors:  J R Heiman
Journal:  Int J Impot Res       Date:  1998-05       Impact factor: 2.896

View more
  4 in total

1.  The interaction between erectile dysfunction complaints and depression in men: a cross-sectional study about sleep, hormones and quality of life.

Authors:  J H Soterio-Pires; C Hirotsu; L J Kim; L Bittencourt; S Tufik; M L Andersen
Journal:  Int J Impot Res       Date:  2016-12-01       Impact factor: 2.896

2.  Sexual dysfunction in cervical dystonia and blepharospasm.

Authors:  M Marek; M Grobe-Einsler; J R Bedarf; B Wabbels; S Paus
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-26       Impact factor: 2.570

Review 3.  Psychosocial interventions for erectile dysfunction.

Authors:  T Melnik; B G O Soares; A G Nasselo
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

4.  Effect of daily tadalafil on reported outcomes in patients with erectile dysfunction and depressive symptoms: STROBE, a case-control study.

Authors:  Kyu Shik Kim; Tae Yoong Jeong; Hong Sang Moon
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.